Mangalam Drugs And Organics Ltd.
Snapshot View

View in App

Prices View details >>

97.85 -1.00 ▼-1.0%

31 March 2023, 04:01:00 PM
Volume: 6,560

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mangalamdrugs.com
Market Cap 154.88 Cr.
Enterprise Value(EV) 222.82 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 7.80 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 12.54 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 98.73 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.99 Calculated using Price: 97.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.58 Cr. 15,828,248 Shares
FaceValue 10
Company Profile
Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.01%
1 Week
-9.48%
1 Month
-6.05%
3 Month
-28.65%
6 Month
-32.63%
1 Year
-4.86%
2 Year
-1.56%
5 Year
-39.65%
10 Year
+1530.83%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -12.28 23.36 38.91 32.11 20.99 -8.05 8.27 23.83 13.97
Return on Capital Employed (%) 5.86 15.69 29.14 30.18 25.35 1.76 10.66 28.01 18.34
Return on Assets (%) -2.53 4.16 9.73 12.76 9.56 -3.67 3.73 11.31 6.64

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 23 29 62 86 104 96 104 131 151 156
Non Curr. Liab. 41 41 25 26 23 25 17 24 48 43
Curr. Liab. 61 99 73 78 100 91 109 109 130 175
Minority Int.
Equity & Liab. 125 170 160 190 227 211 231 264 328 375
Non Curr. Assets 54 54 60 94 104 106 111 130 146 155
Curr. Assets 71 116 100 96 123 105 119 134 182 220
Misc. Exp. not W/O
Total Assets 125 170 160 190 227 211 231 264 328 375

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 123 221 295 303 279 228 282 385 451 402
Other Income 0 0 0 0 1 0 1 0 0
Total Income 123 221 295 303 280 228 284 385 451 402
Total Expenditure -113 -200 -258 -257 -233 -218 -259 -327 -402 -367
PBIDT 10 20 38 46 48 10 25 58 49 36
Interest -10 -10 -9 -10 -12 -9 -10 -9 -11 -12
Depreciation -4 -4 -4 -5 -7 -7 -8 -9 -10 -11
Taxation 1 0 -8 -9 -9 -2 2 -12 -8 0
Exceptional Items
PAT -3 6 16 22 20 -8 8 28 20 12
Adjusted EPS -2 5 11 14 13 -5 5 18 12 8

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 7 14 22 43 25 22 31 28 26
Cash Fr. Inv. -2 -2 -4 -11 -39 -16 -9 -7 -31 -27
Cash Fr. Finan. 2 -5 -10 -11 -3 -9 -11 -23 3 3
Net Change -1 0 1 0 0 0 1 0 -1 1
Cash & Cash Eqvt 0 0 1 1 1 0 1 2 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.53 50.53 50.53 50.53 50.53 50.53 50.42 50.42 50.32
Public 49.47 49.47 49.47 49.47 49.47 49.47 49.58 49.58 49.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 33.57 33.57 33.57 11.59 16.88 19.98 16.97 16.22 16.65

Announcements View Details >>

Fri, 31 Mar 2023
Closure of Trading Window
In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Companys Code for prohibition of Insider Trading the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from April 1 2023 till the expiry of forty-eight (48) hours after the declaration of Audited Financial Results of the Company for the quarter and year ended March 31 2023
Thu, 30 Mar 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended please find enclosed herewith copies of newspaper advertisement regarding Notice of Postal Ballot of the Company information on remote e-voting and other related information published in the following newspaper on Thursday March 30 2023:01) Financial Express 02) Loksatta Mumbai
Thu, 30 Mar 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to the provisions of Section 108 and 110 of the Companies Act 2013 read with Rule 20 and 22 of Companies (Management & Administration) Rules 2014 as amended and all other applicable provisions of Companies Act 2013 including any statutory modification or re-enactment thereof for the time being in force and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and the MCA circulars the Company is in the process of seeking approval of shareholders of the Company by passing the Resolutions as set out in the Postal Ballot Notice dated March 28 2023.

Technical Scans View Details >>

Fri, 31 Mar 2023
Higher Trade Quantity Higher Trade Quantity
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Mangalam Drugs And Organics Ltd.

What is Mangalam Drugs&Org. share price?
Can I buy Mangalam Drugs&Org. shares now?
What is the Market Cap of Mangalam Drugs&Org.?
What are the key metrics to analyse Mangalam Drugs&Org.?
What is the 52 Week High and Low of Mangalam Drugs&Org.?
What is the trend of Mangalam Drugs&Org. share price?